All articles tagged with #lymphoma
A 42-year-old man in the UK discovered via a toothache that he had an aggressive facial cancer. After a mass was found and a CT/biopsy confirmed stage 2 diffuse large B-cell lymphoma, doctors said the tumor had eaten through his facial bone and was inoperable. He began chemotherapy in December but has paused after four rounds due to severe side effects, and he urges others not to ignore minor symptoms that could signal cancer.
Researchers report cf-EpiTracing, an automated platform that profiles multiple histone modifications in cell-free chromatin from as little as 50 μL of plasma to infer tissues of origin with high accuracy; by integrating an 18-ICS ChromHMM framework across reference epigenomes, it identifies primary diseased tissues, detects organ involvement, enables noninvasive cancer subtyping (DLBCL, FL, MCL), early colorectal lesions, prognosis and therapy-response prediction, and tracks disease transformations and translocations. Validated in CRC, CHD and B-cell lymphoma cohorts, cf-EpiTracing outperforms current clinical indices for prognosis and supports longitudinal monitoring, highlighting a versatile, noninvasive epigenome-centric approach that could be integrated with other cfDNA modalities for enhanced precision.
Emma Operacz, a 21-year-old Eastern Michigan University student, went from thinking she had a UTI to a life-threatening stage IV ALK+ anaplastic large cell lymphoma; after a difficult treatment course that included an experimental drug to cross the blood–brain barrier and a sister-donor bone marrow transplant, she spent months recovering before graduating in December 2025 and beginning a graduate program to work with cancer patients.
Bret Hanna-Shuford, a Broadway actor and social media influencer known for his role in productions like Wicked and for documenting his life as a gay parent with his husband Stephen, has died at 46 after battling lymphoma and HLH. He was also working on a children's book and is survived by his family, including his son Maverick.
Dave Coulier, known for 'Full House,' announced he has Stage 3 tongue cancer, diagnosed after a routine PET scan, following his previous battle with lymphoma. He is undergoing 35 rounds of radiation and is optimistic about his prognosis, emphasizing the importance of early detection and healthy products.
Jessica Farrington shared her experience of ignoring early signs of non-Hodgkin follicular lymphoma, emphasizing the importance of listening to one's body and seeking medical attention for subtle symptoms to enable early diagnosis and treatment.
A pregnant woman in England experienced severe symptoms mistaken for morning sickness, but was later diagnosed with a fast-growing lymphoma, leading her to make the difficult decision to terminate her pregnancy to begin life-saving treatment. She has since gone into remission and is raising funds for lymphoma awareness.
Johnson & Johnson's early-stage clinical trial of a dual-targeting CAR-T therapy for lymphoma shows promising results, with a 100% response rate in patients with prior treatment, and manageable safety profile, marking a significant step forward in blood cancer treatment.
Jessica DeCristofaro shares her journey of being misdiagnosed multiple times before discovering she had stage 4B Hodgkin's lymphoma. Initially dismissed as allergies or acid reflux, her persistent symptoms led to a critical diagnosis after visiting numerous doctors. Following intense chemotherapy and radiation, she went into remission and now supports other cancer patients through her blog and care packages. Her story highlights the importance of self-advocacy in healthcare.
NIH researchers have developed a five-drug combination therapy, ViPOR, that achieves lasting remissions in patients with aggressive B-cell lymphoma resistant to standard treatments. In a clinical trial, ViPOR led to complete tumor disappearance in 38% of patients and showed significant survival benefits, particularly in specific subtypes of diffuse large B-cell lymphoma (DLBCL). The treatment's side effects were generally mild to moderate, and further studies are planned to confirm its efficacy and explore its use in other lymphoma types.
A study by Lund University in Sweden found that people with tattoos have a 21% higher risk of developing lymphoma, a rare cancer affecting white blood cells. The research, which included 5,591 participants, suggests that the risk is influenced by the duration of time since getting the tattoo rather than its size. While the findings highlight potential health risks associated with tattoos, more research is needed to provide definitive recommendations.
A study by Lund University in Sweden found that having tattoos is associated with a 21% increased risk of lymphoma, a type of blood cancer. The research, published in eClinical Medicine, analyzed data from the Swedish National Cancer Register and adjusted for various lifestyle factors. While the study highlights a potential health risk, experts emphasize the need for further research to fully understand the link between tattoos and cancer.
A new study from Lund University in Sweden reveals that individuals with tattoos may have a 21% higher risk of developing lymphoma, regardless of the tattoo's size. The study, which involved nearly 12,000 participants, found that the risk is highest among those who got their first tattoo less than two years prior. Researchers call for more studies to understand the long-term health implications of tattoos as their popularity continues to rise.
A Swedish study suggests a potential link between tattoos and malignant lymphoma, but experts argue the findings are overstated and call for more research. The study found a 21% higher risk of lymphoma among tattooed individuals, but this association is not statistically significant. Experts emphasize that the main risk factors for lymphoma are not related to tattooing, and the study's conclusions should be interpreted with caution.
A Swedish study suggests a potential link between tattoos and malignant lymphoma, but experts argue the findings are overstated and more research is needed. The study found a 21% higher risk of lymphoma among those with tattoos, but this association is not statistically significant. Experts emphasize that the main risk factors for lymphoma are not related to tattooing, and the study's conclusions should be interpreted with caution.